Follow
Jason Roberts
Title
Cited by
Cited by
Year
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ...
Critical care medicine 49 (11), e1063-e1143, 2021
41122021
Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the …
AC Kalil, ML Metersky, M Klompas, J Muscedere, DA Sweeney, ...
Clinical infectious diseases 63 (5), e61-e111, 2016
39012016
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ...
Clinical infectious diseases 58 (8), 1072-1083, 2014
10772014
Pharmacokinetic issues for antibiotics in the critically ill patient
JA Roberts, J Lipman
Critical care medicine 37 (3), 840-851, 2009
9922009
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ...
The Lancet infectious diseases 14 (6), 498-509, 2014
9112014
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ...
Intensive care medicine 46, 1127-1153, 2020
6202020
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients
M Ulldemolins, JA Roberts, J Rello, DL Paterson, J Lipman
Clinical pharmacokinetics 50, 99-110, 2011
5082011
Subtherapeutic initial β-lactam concentrations in select critically ill patients
AA Udy, JM Varghese, M Altukroni, S Briscoe, BC McWhinney, ...
Chest 142 (1), 30-39, 2012
4682012
Obesity in the critically ill: a narrative review
M Schetz, A De Jong, AM Deane, W Druml, P Hemelaar, P Pelosi, ...
Intensive care medicine 45, 757-769, 2019
4322019
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial
JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ...
Clinical infectious diseases 56 (2), 236-244, 2013
4322013
Augmented renal clearance: implications for antibacterial dosing in the critically ill
AA Udy, JA Roberts, RJ Boots, DL Paterson, J Lipman
Clinical pharmacokinetics 49, 1-16, 2010
4162010
Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials
JA Roberts, MH Abdul-Aziz, JS Davis, JM Dulhunty, MO Cotta, J Myburgh, ...
American journal of respiratory and critical care medicine 194 (6), 681-691, 2016
4152016
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
JA Roberts, M Ulldemolins, MS Roberts, B McWhinney, J Ungerer, ...
International journal of antimicrobial agents 36 (4), 332-339, 2010
4142010
Antibiotic resistance—what’s dosing got to do with it?
JA Roberts, P Kruger, DL Paterson, J Lipman
Critical care medicine 36 (8), 2433-2440, 2008
4132008
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and …
JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ...
Journal of antimicrobial chemotherapy 64 (1), 142-150, 2009
3842009
Therapeutic drug monitoring of antimicrobials
JA Roberts, R Norris, DL Paterson, JH Martin
British journal of clinical pharmacology 73 (1), 27-36, 2012
3822012
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis
JA Roberts, J Lipman
Clinical pharmacokinetics 45, 755-773, 2006
3792006
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation
K Shekar, JF Fraser, MT Smith, JA Roberts
Journal of critical care 27 (6), 741. e9-741. e18, 2012
3332012
The clinical relevance of plasma protein binding changes
JA Roberts, F Pea, J Lipman
Clinical pharmacokinetics 52, 1-8, 2013
3312013
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in …
MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai, KK Wong, MS Hasan, ...
Intensive care medicine 42, 1535-1545, 2016
3162016
The system can't perform the operation now. Try again later.
Articles 1–20